Table 3A.
Therapeutic efficacy of NSAID therapy before and 3 months after starting treatment
| Parameter | Before |
3 months after starting treatment |
Significance |
| VAS | 69.3 ± 5.46 | 28.6 ± 11.3 | S.D (p = 0.0277) |
| RDQ | 8.92 ± 1.08 | 3.43 ± 1.49 | N.S (p = 0.0618) |
| SF-36 (eight scaled scores) | |||
| 1) physical functioning | 36.1 ± 5.87 | 43.1 ± 5.48 | N.S (p = 0.8413) |
| 2) role physical | 41.0 ± 2.95 | 40.2 ± 4.37 | N.S (p = 0.8781) |
| 3) bodily pain | 31.5 ± 1.75 | 37.4 ± 2.62 | N.S (p = 0.3341) |
| 4) general health | 41.5 ± 2.49 | 45.1 ± 2.33 | N.S (p = 0.5088) |
| 5) vitality | 42.7 ± 2.44 | 45.0 ± 3.54 | N.S (p = 0.8138) |
| 6) social functioning | 42.9 ± 2.37 | 47.7 ± 4.50 | N.S (p = 0.4554) |
| 7) role emotional | 44.4 ± 3.84 | 45.1 ± 4.97 | N.S (p = 0.7822) |
| 8) mental health | 46.0 ± 2.70 | 48.0 ± 3.61 | S.D (p = 0.0277) |
Data are the mean ± standard error or the number unless otherwise indicated.
N.S: Not significant
NSAID: Nonsteroidal anti-inflammatory drug
RDQ: Roland Morris Disability Questionnaire score
S.D: Significant difference
SF-36: 36-Item Short-Form Health Survey
VAS: Visual analog scale